SecurityROSE / Rosehill Resources Inc. (777385105)
Institutional Owners33
Institutional Shares1,953,663 - 6.55%
Common Shares Outstanding229,807,692 shares (as of 2018-03-31)
Institutional Value$ 13,822,000 USD
Related ROSEU / Rosehill Resources
ROSEW / Rosehill Resources, Warrants

Institutional Stock Ownership and Shareholders()

ROSE / Rosehill Resources Inc. Institutional Ownership

Rosehill Resources Inc. (NASDAQ:ROSE) has 33 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,953,663 shares. Largest shareholders include K2 Principal Fund, L.p., Anchorage Capital Group, L.L.C., Quantum Capital Management, Wells Fargo & Company/mn, Cullen/frost Bankers, Inc., BlackRock Inc., Cubic Asset Management, LLC, Vanguard Group Inc, Us Bancorp \de\, and Morgan Stanley.
Rosehill Resources Inc. (NASDAQ:ROSE) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/rose"><img src="https://images.fintel.io/us-rose-so.png" alt="ROSE / Rosehill Resources Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR PANAGORA ASSET MANAGEMENT INC 4,545 4,545 0.00 36 27 -25.00
2018-05-14 13F-HR K2 PRINCIPAL FUND, L.P. 457,115 460,615 0.77 3,234 1,901 -41.22
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 377 221 -41.38 3 1 -66.67
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 220 220 0.00 2 1 -50.00
2018-05-15 13F-HR DEUTSCHE BANK AG\ 7,509 2,717 -63.82 57 15 -73.68
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 2 1 -50.00 0 0
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 51,803 0 -100.00 406 0 -100.00
2018-05-14 13F-HR TEACHERS ADVISORS INC 2,865 0 -100.00 23 0 -100.00
2018-05-10 13F-HR Stratos Wealth Partners, LTD. 5,900 9,900 67.80 46 58 26.09
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 4,500 4,500 0.00 35 26 -25.71
2018-05-08 13F-HR US BANCORP \DE\ 32,500 32,500 0.00 255 191 -25.10
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ 90 32 -64.44 1 0 -100.00
2018-05-11 13F-HR CITIGROUP INC 41 1 -97.56 0 0
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 114 162 42.11 0 0
2018-05-15 13F-HR VANGUARD GROUP INC 120,898 120,690 -0.17 950 709 -25.37
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 11,800 11,800 0.00 93 69 -25.81
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 378 0 -100.00 3 0 -100.00
2018-05-09 13F-HR BlackRock Inc. 131,055 135,759 3.59 1,031 796 -22.79
2018-05-15 13F-HR STATE STREET CORP 16,646 18,346 10.21 130 108 -16.92
2018-05-14 13F-HR WESTWOOD HOLDINGS GROUP INC 222,578 0 -100.00 1,749 0 -100.00
2018-05-15 13F-HR BARCLAYS PLC 400 523 30.75 3 3 0.00
2018-05-11 13F-HR CULLEN/FROST BANKERS, INC. 138,527 138,527 0.00 1,089 813 -25.34
2018-04-24 13F-HR Cubic Asset Management, LLC 135,450 128,875 -4.85 1,065 756 -29.01
2018-05-17 13F-HR Legal & General Group Plc 288 288 0.00 2 2 0.00
2018-05-15 13F-HR Anchorage Capital Group, L.L.C. 413,002 413,002 0.00 3,246 2,424 -25.32
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 0 2,503 0 15
2018-05-11 13F-HR SEI INVESTMENTS CO 214 0 -100.00 2 0 -100.00
2018-05-14 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 0 12,801 0 75
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 541 539 -0.37 4,252 3,164 -25.59
2018-05-09 13F-HR NORTHERN TRUST CORP 23,452 23,452 0.00 185 138 -25.41
2018-05-14 13F-HR MORGAN STANLEY 25,322 26,771 5.72 199 157 -21.11
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 3,946 0 -100.00 31 0 -100.00
2018-04-16 13F-HR Malaga Cove Capital, LLC 0 11,300 0 66
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 1,698 1,610 -5.18 13 9 -30.77
2018-05-15 13F-HR UBS Group AG 39,800 0 -100.00 313 0 -100.00
2018-05-07 13F-HR QUANTUM CAPITAL MANAGEMENT 93,209 214,442 130.07 733 1,259 71.76
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 147,808 155,546 5.24 1,162 913 -21.43
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 11,525 18,600 61.39 91 109 19.78
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 1,490 2,367 58.86 12 14 16.67
2018-05-10 13F-HR JP Morgan Chase & Co 543 508 -6.45 4 3 -25.00

Related Articles

HIMX: Himax Technologies Analysis and Research Report

7h - Asif

History and Development Himax Taiwan, its predecessor, was incorporated on June 12, 2001 as a limited liability company under the laws of the ROC. On April 26, 2005, the company established Himax Technologies Limited, an exempted company with limited liability under the Cayman Islands Companies Law, as a holding company to hold the shares of Himax Taiwan in connection with its reorganization and share exchange. On October 14, 2005, Himax Taiwan became its wholly owned subsidiary through a share exchange consummated pursuant to the ROC Business Mergers and Acquisitions Law through which the company acquired all of the issued and outstanding shares of Himax Taiwan, and the company issued ordinary shares to the shareholders of Himax Taiwan. Shareholders of Himax Taiwan received one of its ordinary shares in exchange for one Himax Taiwan common share. The share exchange was unanimously approved by shareholders of Himax Taiwan on June 10, 2005 with no dissenting shareholders and by ...

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

Related News Stories

Rosehill Resources' (ROSE) CEO Alan Townsend on Q1 2018 Results - Earnings Call Transcript

2018-05-15 seekingalpha
Good day, ladies and gentlemen and welcome to the Rosehill Resources' First Quarter 2018 Conference Call. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder, today's program maybe recorded. (1-0)

Fifth Third's (FITB) Q1 Earnings & Revenues Beat Estimates

2018-04-24 zacks
Have you been eager to see how Fifth Third Bancorp (FITB - Free Report) performed in Q1 in comparison with the market expectations? Let’s quickly scan through the key facts from this Ohio-based bank’s earnings release this morning: An Earnings Beat Fifth Third came out with adjusted earnings per share of 57 cents, surpassing the Zacks Consensus Estimate of 48 cents. The figure excludes the net positive impact of gain from the Vantiv merger with WorldPay and charges related to the valuation of the Visa total return swap and adjustment to litigation reserves. (72-0)

Can The Uptrend Continue for Rosehill Resources (ROSE)?

2018-04-23 zacks
Investors certainly have to be happy with Rosehill Resources Inc. (ROSE - Free Report) and its short term performance. After all, the stock has jumped by 23.3% in the past 4 weeks, and it is also above its 20 Day Simple Moving Average as well. This is certainly a good trend, but investors are probably asking themselves, can this positive trend continue for ROSE? (8-0)

Construct Your Oil Portfolio: The Capital Appreciation Version

2018-04-23 seekingalpha
This is Part 3 of a three-piece series aiming to take a long, hard look at how to go about building an oil stock portfolio that fits your personality. (20-1)

CUSIP: 777385105